The global high-affinity nerve growth factor receptor market is anticipated to grow at a significant CAGR of 5.4% during the forecast period 2022-2028. The major factor attributed to the growth of the market is the rising prevalence of atopic dermatitis across the globe. As per the information provided by the National Eczema Association which highlighted the fact that around 9.6 million US children under the age of 18 have atopic dermatitis, along with one-third have moderate to severe diseases, and childhood atopic dermatitis has steadily increased from 8% to 12% since 1997. Moreover, the major players in the industry are going on with research and development activities to bring up new products in the market for the treatment of atopic dermatitis. The mergers between the companies for the development of these products are supporting the market to grow further.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/high-affinity-nerve-growth-factor-receptor-market
For instance, in February 2022, Akeso, Inc. announced that the clinical trial application of the innovative nerve growth factor (NGF) monoclonal antibody injection developed in-house by the Company, has obtained approval from the Centre for Drug Evaluation of China’s National Medical Products Administration to begin a clinical trial for the treatment of pain (including cancer pain).
Further, in June 2021, Amgen Inc. and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin’s potential first-in-class, Phase 3-ready anti-OX40 fully human monoclonal antibody in development for the treatment of atopic dermatitis, with potential in other autoimmune diseases.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including, GlaxoSmithKline PLC, Sanofi SA, Merck & Co. inc., Pfizer Inc., Novartis International AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global High-Affinity Nerve Growth Factor Receptor Market Report Segment
By Drug Type
- ASP-7962
- AZD-7451
- BNN-27
- Cenegermin
- CRB-0089
- Others
By Application
- Atopic Dermatitis
- Cancer
- Others
A full report of High Affinity Nerve Growth Factor Receptor Market is available at: https://www.omrglobal.com/industry-reports/high-affinity-nerve-growth-factor-receptor-market
High Affinity Nerve Growth Factor Receptor Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Akeso, Inc.
- Genzyme Corp.
- Handok Inc.
- Ignyta Inc.
- Kyowa Kirin Co., Ltd.
- Loxo Oncology Inc.
- Merck & Co. Inc.
- Nerviano Medical Sciences Srl
- Pfizer Inc.
- Plexxicon Inc.
- Proximagen Ltd.
- Rottapharm Biotech Srl
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
